Repligen (RGEN) Revenue & Revenue Breakdown
Repligen Revenue Highlights
Latest Revenue (Y)
$638.76M
Latest Revenue (Q)
$154.07M
Main Segment (Y)
Product
Repligen Revenue by Period
Repligen Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $638.76M | -20.31% |
| 2022-12-31 | $801.54M | 19.54% |
| 2021-12-31 | $670.53M | 83.08% |
| 2020-12-31 | $366.26M | 35.53% |
| 2019-12-31 | $270.25M | 39.28% |
| 2018-12-31 | $194.03M | 37.38% |
| 2017-12-31 | $141.24M | 35.10% |
| 2016-12-31 | $104.54M | 25.14% |
| 2015-12-31 | $83.54M | 31.45% |
| 2014-12-31 | $63.55M | -6.78% |
| 2013-12-31 | $68.17M | 9.48% |
| 2012-12-31 | $62.27M | 128.16% |
| 2011-03-31 | $27.29M | 30.14% |
| 2010-03-31 | $20.97M | -28.58% |
| 2009-03-31 | $29.36M | 52.16% |
| 2008-03-31 | $19.30M | 37.10% |
| 2007-03-31 | $14.07M | 9.01% |
| 2006-03-31 | $12.91M | 37.94% |
| 2005-03-31 | $9.36M | 35.38% |
| 2004-03-31 | $6.91M | -11.03% |
| 2003-03-31 | $7.77M | 80.67% |
| 2002-03-31 | $4.30M | 83.30% |
| 2001-03-31 | $2.35M | -31.99% |
| 2000-03-31 | $3.45M | 32.72% |
| 1999-03-31 | $2.60M | 8.33% |
| 1998-03-31 | $2.40M | -36.84% |
| 1997-03-31 | $3.80M | -65.14% |
| 1996-03-31 | $10.90M | -35.50% |
| 1995-03-31 | $16.90M | -36.94% |
| 1994-03-31 | $26.80M | -1.83% |
| 1993-03-31 | $27.30M | - |
Repligen generated $638.76M in revenue during NA 2023, up -20.31% compared to the previous quarter, and up 329.21% compared to the same period a year ago.
Repligen Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $154.07M | 1.80% |
| 2024-03-31 | $151.35M | -2.82% |
| 2023-12-31 | $155.74M | 10.31% |
| 2023-09-30 | $141.19M | -11.29% |
| 2023-06-30 | $159.17M | -12.86% |
| 2023-03-31 | $182.66M | -2.20% |
| 2022-12-31 | $186.76M | -6.96% |
| 2022-09-30 | $200.74M | -3.32% |
| 2022-06-30 | $207.63M | 0.60% |
| 2022-03-31 | $206.40M | 10.66% |
| 2021-12-31 | $186.52M | 4.66% |
| 2021-09-30 | $178.22M | 9.36% |
| 2021-06-30 | $162.96M | 14.09% |
| 2021-03-31 | $142.84M | 31.47% |
| 2020-12-31 | $108.65M | 15.51% |
| 2020-09-30 | $94.06M | 7.54% |
| 2020-06-30 | $87.46M | 14.95% |
| 2020-03-31 | $76.09M | 9.52% |
| 2019-12-31 | $69.47M | 0.04% |
| 2019-09-30 | $69.44M | -1.76% |
| 2019-06-30 | $70.69M | 16.59% |
| 2019-03-31 | $60.63M | 16.73% |
| 2018-12-31 | $51.94M | 4.87% |
| 2018-09-30 | $49.53M | 3.77% |
| 2018-06-30 | $47.73M | 6.47% |
| 2018-03-31 | $44.83M | 7.74% |
| 2017-12-31 | $41.61M | 13.75% |
| 2017-09-30 | $36.58M | 12.71% |
| 2017-06-30 | $32.45M | 6.10% |
| 2017-03-31 | $30.59M | 19.50% |
| 2016-12-31 | $25.60M | 3.74% |
| 2016-09-30 | $24.68M | -15.40% |
| 2016-06-30 | $29.17M | 16.24% |
| 2016-03-31 | $25.09M | 16.99% |
| 2015-12-31 | $21.45M | 8.25% |
| 2015-09-30 | $19.81M | -7.66% |
| 2015-06-30 | $21.46M | 3.08% |
| 2015-03-31 | $20.82M | 26.98% |
| 2014-12-31 | $16.39M | 7.30% |
| 2014-09-30 | $15.28M | -1.75% |
| 2014-06-30 | $15.55M | -4.75% |
| 2014-03-31 | $16.33M | 6.13% |
| 2013-12-31 | $15.38M | -18.27% |
| 2013-09-30 | $18.82M | 7.50% |
| 2013-06-30 | $17.51M | 6.40% |
| 2013-03-31 | $16.46M | -12.53% |
| 2012-12-31 | $18.81M | 24.56% |
| 2012-09-30 | $15.10M | -2.70% |
| 2012-06-30 | $15.52M | 21.05% |
| 2012-03-31 | $12.82M | 48.58% |
| 2011-09-30 | $8.63M | 12.77% |
| 2011-06-30 | $7.65M | 29.58% |
| 2011-03-31 | $5.91M | -16.43% |
| 2010-12-31 | $7.07M | -3.27% |
| 2010-09-30 | $7.31M | 4.24% |
| 2010-06-30 | $7.01M | 43.87% |
| 2010-03-31 | $4.87M | -13.26% |
| 2009-12-31 | $5.62M | 3.63% |
| 2009-09-30 | $5.42M | 7.11% |
| 2009-06-30 | $5.06M | 10.17% |
| 2009-03-31 | $4.59M | -23.66% |
| 2008-12-31 | $6.02M | 18.23% |
| 2008-09-30 | $5.09M | -62.74% |
| 2008-06-30 | $13.66M | 313.85% |
| 2008-03-31 | $3.30M | - |
Repligen generated $154.07M in revenue during Q2 2024, up 1.80% compared to the previous quarter, and up 84.35% compared to the same period a year ago.
Repligen Revenue Breakdown
Repligen Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Process Analytics Products | $56.82M | $53.51M | $48.02M | $33.35M | $16.41M |
| Product | $638.38M | $801.18M | $670.32M | $366.14M | $270.10M |
| Proteins Products | $103.46M | $114.32M | $123.71M | $80.73M | $65.12M |
| Chromatography Products | $126.63M | $131.68M | $91.04M | $73.55M | $64.64M |
| Filtration Products | $347.78M | $495.93M | $403.50M | $174.90M | $119.53M |
| Other products | $3.69M | $5.74M | $4.05M | $3.61M | $4.40M |
Repligen's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (50.00%), Filtration Products (27.24%), Chromatography Products (9.92%), Proteins Products (8.10%), Process Analytics Products (4.45%), and Other products (0.29%).
Quarterly Revenue by Product
| Product/Service | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $154.04M | $151.31M | $155.47M | $141.16M | $159.13M | $182.62M | $186.51M | $200.71M | $207.60M | $206.36M | $186.49M | $178.18M | $162.92M | $142.74M | $108.61M | $94.03M | $87.43M | $76.06M | $69.40M | $69.42M |
| Royalty | $35.00K | $36.00K | $36.00K | $36.00K | $39.00K | $247.00K | $33.00K | $36.00K | $37.00K | $36.00K | $39.00K | $40.00K | $100.00K | $33.00K | $31.00K | $30.00K | $30.00K | $78.00K | $26.00K | - |
Repligen's latest quarterly revenue breakdown by segment (product or service), as of Jun 24: Product (99.98%), and Royalty (0.02%).
Repligen Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Sep 18 | Jun 18 | Mar 18 |
|---|---|---|---|
| All Other | $62.00K | $55.00K | $243.00K |
| Europe | $19.33M | $19.58M | $19.40M |
| North America | $24.06M | $22.48M | $20.24M |
| Asia and Australia | $6.08M | $5.62M | - |
| Asia Pacific | - | - | $4.95M |
Repligen's latest quarterly revenue breakdown by geography, as of Sep 18: North America (48.59%), Europe (39.02%), Asia and Australia (12.27%), and All Other (0.13%).
Repligen Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| BDX | Becton, Dickinson and Company | $19.37B | $4.99B |
| ISRG | Intuitive Surgical | $7.12B | $2.01B |
| RMD | ResMed | $4.69B | $1.20B |
| HOLX | Hologic | $4.03B | $1.01B |
| COO | Cooper Companies | $3.59B | $1.00B |
| ATR | AptarGroup | $3.49B | $910.06M |
| TFX | Teleflex | $2.97B | $749.69M |
| WST | West Pharmaceutical Services | $2.95B | $702.00M |
| NVST | Envista | $2.57B | $623.60M |
| ICUI | ICU Medical | $2.26B | $596.46M |
| HAE | Haemonetics | $1.31B | $336.17M |
| MMSI | Merit Medical Systems | $1.26B | $338.00M |
| RGEN | Repligen | $638.76M | $154.07M |
| ANGO | AngioDynamics | $303.91M | $75.18M |
RGEN Revenue FAQ
What is Repligen’s yearly revenue?
Repligen's yearly revenue for 2023 was $638.76M, representing a decrease of -20.31% compared to 2022. The company's yearly revenue for 2022 was $801.54M, representing an increase of 19.54% compared to 2021. RGEN's yearly revenue for 2021 was $670.53M, representing an increase of 83.08% compared to 2020.
What is Repligen’s quarterly revenue?
Repligen's quarterly revenue for Q2 2024 was $154.07M, a 1.80% increase from the previous quarter (Q1 2024), and a -3.20% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $151.35M, a -2.82% decrease from the previous quarter (Q4 2023), and a -17.14% decrease year-over-year (Q1 2023). RGEN's quarterly revenue for Q4 2023 was $155.74M, a 10.31% increase from the previous quarter (Q3 2023), and a -16.61% decrease year-over-year (Q4 2022).
What is Repligen’s revenue growth rate?
Repligen's revenue growth rate for the last 3 years (2021-2023) was -4.74%, and for the last 5 years (2019-2023) was 136.36%.
What are Repligen’s revenue streams?
Repligen's revenue streams in c 23 are Process Analytics Products, Product, Proteins Products, Chromatography Products, Filtration Products, and Other products. Process Analytics Products generated $56.82M in revenue, accounting 4.45% of the company's total revenue, up 6.18% year-over-year. Product generated $638.38M in revenue, accounting 50.00% of the company's total revenue, down -20.32% year-over-year. Proteins Products generated $103.46M in revenue, accounting 8.10% of the company's total revenue, down -9.50% year-over-year. Chromatography Products generated $126.63M in revenue, accounting 9.92% of the company's total revenue, down -3.84% year-over-year. Filtration Products generated $347.78M in revenue, accounting 27.24% of the company's total revenue, down -29.87% year-over-year. Other products generated $3.69M in revenue, accounting 0.29% of the company's total revenue, down -35.76% year-over-year.
What is Repligen’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Repligen was Product. This segment made a revenue of $638.38M, representing 50.00% of the company's total revenue.